Press release

  • 2024-01-31

    ImmuneBiotech Medical Sweden AB strengthens its Board of Directors by welcoming life science professional Sara Malcus as Chairman of the Board and Svante Hjertén as Board Member
  • 2023-05-11

    ImmuneBiotech Medical Sweden AB announces the appointment of international microbiome expert Kristin Wannerberger to board of directors
  • 2021-01-20

    ImmuneBiotech closes fully subscribed new share issue with funding from recognized investors and existing shareholders
  • 2020-09-22

    ImmuneBiotech: Patent granted for GutMagnific® in the United States
  • 2020-06-10

    ImmuneBiotech: starts clinical trial of GutMagnific® in ME/CFS in collaboration with Stora Sköndal ME clinic
  • 2019-10-16

    ImmuneBiotech: market launch of first product GutMagnific
  • 2019-05-07

    ImmuneBiotech: Winner of H2020 “SME Instrument” Phase 1
  • 2019-01-24

    ImmuneBiotech closes new share issue with funding from recognized international investors and business angels

News

Press contact

For media inquiries, please write to info@immunebiotech.com

ImmuneBiotech AB
Scheelevägen 2, Medicon Village
223 81 Lund, Sweden
Phone: +46 46 25 25 50
GutMagnific Web Shop: www.GutMagnific.com

Follow us on LinkedIn for the latest updates and information.